Global Non-Invasive Prenatal Testing (NIPT) Market

Global Non-Invasive Prenatal Testing (NIPT) Market: Focus on Tests, Methods, Platforms, Applications, 26 Countries’ Analysis, Patent Landscape, and Competitive Landscape - Analysis and Forecast, 2018-2028

The global NIPT market is expected to reach $5.67 billion with 7,591,792 units by 2028.

SKU: BH017F
Published Year: 2018
PLEASE SELECT A LICENSE TYPE
 
 
 

The life science industry is focused on the development of advanced NIPT tests using genome sequencing technologies for the early detection of genetic disorders. The increasing prevalence of genetic disorders and development of the healthcare infrastructure are promoting the adoption of the NIPT for better diagnosis and improved prenatal care.

Non-invasive prenatal testing (NIPT) is a sophisticated method used for the screening of chromosomal abnormalities developing in the fetus. Currently, NIPT is considered as a valuable test for the pregnant women to provide cost-effective and highly efficient early diagnosis of genetic disorders. Moreover, advancements in genome sequencing technologies reduce turnaround time and the complexity of diagnosis with next generation sequencing (NGS). The NGS technology provides several opportunities to develop the non-invasive diagnostic procedures for an early and accurate detection of various genetic disorders. The life science industry is witnessing significant growth of NIPT tests developed using the NGS technology. Several biotechnology companies are now indulging in the research and development of such NGS-based NIPT products. Furthermore, the advent of genome sequencing technologies in the life science industry has enabled the companies to detect the genetic diseases at an early stage and provide accurate results to remain competitive in the market.

The purpose of this study is to gain a holistic view of the NIPT market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the tests associated with the global NIPT market across different regions. The market has been segmented into ‘tests,’ ‘methods,’ ‘platforms,’ ‘applications,’ and ‘regions.’ The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering various aspects of the global NIPT market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global NIPT market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment, the key market trends, list of the key companies, and the key strategies and developments have also been discussed.

The answers to the following key questions can be derived from this report:

•    How did the NIPT market evolve, and what is its scope in the future?
•    What are the major market drivers, challenges, and opportunities in the global NIPT market?
•    What are the key developmental strategies that are implemented by the key players to sustain in this market?
•    How the influencing factors will affect the industry attractiveness?
•    How NIPT is utilized for the detection of chromosomal abnormalities?
•    How investments by public and private companies and government organizations will affect the global NIPT market? 
•    What was the market size of the leading segments and sub-segments of the global NIPT market in 2017?
•    How will the industry evolve during the forecast period 2018-2028?
•    What will be the growth rate of the NIPT during the forecast period?
•    How will each segment of the global NIPT market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028?
•    Which test segment, and application segment is expected to register the highest CAGR for the NIPT market?
•    What is the market size of NIPT in different countries of the world?
•    Which geographical region will contribute to the highest sales of NIPT?
•    Who are the key players in the NIPT market, and what are their contributions?

The key players who have been contributing significantly to the NIPT market include Agilent Technologies, Inc., Annoroad Gene Technology, Berry Genomics Co., Ltd., BGI Diagnosis, Centogene AG, Counsyl, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Next Biosciences, NIPD Genetics, PerkinElmer, Inc., Premaitha Health Plc, and Quest Diagnostics Incorporated, among others.

   Executive Summary
   1   Market Overview
        1.1   Introduction
        1.2   NIPT Approach
        1.3   Different Methods of NIPT
        1.4   Benefits and Risks Associated with NIPT
        1.5   Technological Advancements
        1.6   World Economic Outlook of Prenatal Testing Market, 2017
        1.7   Global NIPT Market Scenario
        1.8   Assumptions and Limitations for Market Size Calculations
 
   2   Market Dynamics
        2.1   Overview
        2.2   Impact Analysis
        2.3   Market Drivers
        2.4   Market Restraints
        2.5   Market Opportunities
 
   3   Competitive Landscape
        3.1   Introduction
        3.2   Key Developments and Strategies
                3.2.1   Product Launches and Enhancements
                3.2.2   Joint Ventures, Partnerships, and Collaborations
                3.2.3   Mergers and Acquisitions
                3.2.4   Business Expansions, Awards, Recognitions, Certifications, and Others
        3.3   Market Share Analysis
        3.4   Growth Share Matrix (by Test), 2017
        3.5   Growth Share Matrix (by Region), 2017
        3.6   Key Stakeholders of NIPT Market
        3.7   Industry Attractiveness
                3.7.1   Bargaining Power of Suppliers
                3.7.2   Bargaining Power of Buyers
                3.7.3   Threat of New Entrants
                3.7.4   Threat of Substitute Products
                3.7.5   Intensity of Competitive Rivalry
 
   4   Industry Insights
        4.1   Introduction
        4.2   Patent Analysis
        4.3   Clinical Laboratory Improvement Amendments (CLIA) Program
        4.4   List of Regulatory Bodies
 
   5   Global Non-Invasive Prenatal Testing (NIPT) Market (by Test)
        5.1   Overview
        5.2   Verifi
        5.3   MaterniT21 PLUS and MaterniT GENOME
        5.4   PrenaTest, GeneSafe, and PrenatalSAFE
        5.5   Panorama
        5.6   QNatal Advanced
        5.7   Harmony
        5.8   IONA
        5.9   NIFTY
       5.10  Bambni
       5.11  Others
 
   6   Global Non-Invasive Prenatal Testing (NIPT) Market (by Method)
        6.1   Overview
        6.2   cf-DNA
        6.3   FCMB
 
   7   Global Non-Invasive Prenatal Testing (NIPT) Market (by Platform)
        7.1   Overview
        7.2   NGS
        7.3   MPSS
        7.4   Others
 
   8   Global Non-Invasive Prenatal Testing (NIPT) Market (by Application)
        8.1   Overview
        8.2   Trisomy Detection
        8.3   Microdeletion Detection
        8.4   Others
 
   9   Global Non-Invasive Prenatal Testing (NIPT) Market (by Region)
        9.1   Overview
        9.2   Global Insights
        9.3   North America
                9.3.1   North America Market Dynamics
                9.3.2   North America Market (by Country)
                           9.3.2.1   The U.S.
                           9.3.2.2   Canada
        9.4   Europe
                9.4.1   Europe Market Dynamics
                9.4.2   Europe Market (by Country)
                           9.4.2.1   The U.K.
                           9.4.2.2   Germany
                           9.4.2.3   France
                           9.4.2.4   Italy
                           9.4.2.5   Spain
                           9.4.2.6   The Netherlands
                           9.4.2.7   Belgium
                           9.4.2.8   Switzerland
                           9.4.2.9   Sweden
                           9.4.2.10  Denmark
                           9.4.2.11  Poland
                           9.4.2.12  Russia
                           9.4.2.13  Rest-of-Europe
        9.5   Asia-Pacific
               9.5.1   Asia-Pacific Market Dynamics
               9.5.2   Asia-Pacific (by Country)
                          9.5.2.1   China
                          9.5.2.2   Japan
                          9.5.2.3   Australia
                          9.5.2.4   India
                          9.5.2.5   Singapore
                          9.5.2.6   Hong Kong 
                          9.5.2.7   Malaysia
                          9.5.2.8   Indonesia
                          9.5.2.9   Vietnam
                          9.5.2.10  South Korea
                          9.5.2.11  Philippines
                          9.5.2.12  Thailand
                          9.5.2.13  Rest-of-Asia-Pacific
        9.6   Rest-of-the-World
 
   10   Company Profiles
          10.1   Overview
          10.2   Agilent Technologies, Inc.
                    10.2.1   Overview
                    10.2.2   Corporate Summary
                    10.2.3   Product Offerings for Global NIPT Market
                    10.2.4   Financials
                                 10.2.4.1   Financial Summary
                    10.2.5   SWOT Analysis
          10.3   Annoroad Gene Technology
                    10.3.1   Overview
                    10.3.2   Corporate Summary
                    10.3.3   Product Offerings for Global NIPT Market
                    10.3.4   SWOT Analysis
          10.4   Berry Genomics Co., Ltd.
                    10.4.1   Overview
                    10.4.2   Corporate Summary
                    10.4.3   Product Offerings for Global NIPT Market
                    10.4.4   SWOT Analysis
          10.5   BGI Diagnosis
                    10.5.1   Overview
                    10.5.2   Corporate Summary
                    10.5.3   Product Offerings for Global NIPT Market
                    10.5.4   SWOT Analysis
          10.6   Centogene AG
                    10.6.1   Overview
                    10.6.2   Corporate Summary
                    10.6.3   Product Offerings for Global NIPT Market
                    10.6.4   SWOT Analysis
          10.7   Counsyl, Inc. (Subsidiary of  Myriad Genetics, Inc.)
                    10.7.1   Overview
          10.8   Myriad Genetics, Inc.
                    10.8.1   Overview
                    10.8.2   Corporate Summary
                    10.8.3   Product Offerings for Global NIPT Market
                    10.8.4   Financials
                                 10.8.4.1   Financial Summary
                    10.8.5   SWOT Analysis
          10.9   LifeCodexx AG (Subsidiary of Eurofins Scientific)
                    10.9.1   Overview
         10.10  EUROFINS Genoma Group (Subsidiary of Eurofins Scientific)
                    10.10.1   Overview
         10.11  Eurofins Scientific
                   10.11.1   Overview
                   10.11.2   Corporate Summary
                   10.11.3   Product Offerings for Global NIPT Market
                   10.11.4   Financials
                                  10.11.4.1   Financial Summary
                   10.11.5   SWOT Analysis
         10.12  F. Hoffmann-La Roche AG
                    10.12.1   Overview
                    10.12.2   Corporate Summary
                    10.12.3   Product Offerings for Global NIPT Market
                    10.12.4   Financials
                                   10.12.4.1   Financial Summary
                    10.12.5   SWOT Analysis
          10.13  Illumina, Inc.
                     10.13.1   Overview
                     10.13.2   Corporate Summary
                     10.13.3   Product Offerings for Global NIPT Market
                     10.13.4   Financials
                                    10.13.4.1   Financial Summary
                      10.13.5   SWOT Analysis
           10.14  Natera, Inc.
                      10.14.1   Overview
                      10.14.2   Corporate Summary
                      10.14.3   Product Offerings for Global NIPT Market
                      10.14.4   Financials
                                     10.14.4.1   Financial Summary
                       10.14.5   SWOT Analysis
            10.15  Next Biosciences
                       10.15.1   Overview
                       10.15.2   Corporate Summary
                       10.15.3   Product Offerings for Global NIPT Market
                       10.15.4   SWOT Analysis
            10.16  NIPD Genetics
                       10.16.1   Overview
                       10.16.2   Corporate Summary
                       10.16.3   Product Offerings for Global NIPT Market
                       10.16.4   SWOT Analysis
            10.17  PerkinElmer, Inc.
                       10.17.1   Overview
                       10.17.2   Corporate Summary
                       10.17.3   Product Offerings for Global NIPT Market
                       10.17.4   Financials
                                      10.17.4.1   Financial Summary
                       10.17.5   SWOT Analysis
            10.18  Premaitha Health Plc
                       10.18.1   Overview
                       10.18.2   Corporate Summary
                       10.18.3   Product Offerings for Global NIPT Market
                       10.18.4   Financials
                                      10.18.4.1   Financial Summary
                       10.18.5   SWOT Analysis
            10.19  Quest Diagnostics Incorporated
                       10.19.1   Overview
                       10.19.2   Corporate Summary
                       10.19.3   Product Offerings for Global NIPT Market
                       10.19.4   Financials
                                      10.19.4.1   Financial Summary
                       10.19.5   SWOT Analysis
            10.20  Sequenom, Inc. (Subsidiary of Laboratory Corporation of America Holdings)
                       10.20.1   Overview
            10.21   Laboratory Corporation of America Holdings
                        10.21.1   Overview
                        10.21.2   Corporate Summary
                        10.21.3   Product Offerings for Global NIPT Market
                        10.21.4   Financials
                                       10.21.4.1   Financial Summary
                        10.21.5   SWOT Analysis
 
   11   Report Scope and Methodology
          11.1   Scope of the Report
          11.2   Global NIPT Market Segmentation
          11.3   Research Methodology
                    11.3.1   Primary Research
                    11.3.2   Secondary Research
                    11.3.3   Key Data Points from Primary Sources 
                    11.3.4   Key Data Points from Secondary Sources 
                    11.3.5   Data Triangulation
                    11.3.6   Top-Down Approach (Segment Wise Analysis)
                    11.3.7   Bottom-Up Approach (Segmental Analysis)
          11.4   Assumptions and Limitations
          11.5   Data and Prediction Modelling
 
I    Annexure 1: Recent Key Developments (2014 – 2018)
II   Annexure 2: Product Mapping
III  Annexure 3: Patent Landscape
 

List of Tables

1    Global NIPT Market (2017 and 2028)
2    Major Chromosomal Aneuploidies
3    Incidence Rate of Major Chromosomal Aneuploidies
4    Technological Approach for NIPT
5    Impact Analysis of Market Dynamics
6    List of Regulatory Authorities involved in CLIA Program 
7    List of Regulatory Bodies
8    NIPT Market (by Test), 2017-2028, ($Million)
9    NIPT Market (by Test), 2017-2028, (Units)
10    North America NIPT Market (by Test), 2017-2028, ($Million)
11    North America NIPT Market (by Test), 2017-2028, (Units)
12    Europe NIPT Market (by Test), 2017-2028, ($Million)
13    Europe NIPT Market (by Test), 2017-2028, (Units)
14    Europe NIPT Market (by Country), 2017-2028, ($Million)
15    Europe NIPT Market (by Country), 2017-2028, (Units)
16    Asia-Pacific NIPT Market (by Test), 2017-2028, ($Million)
17    Asia-Pacific NIPT Market (by Test), 2017-2028, (Units)
18    Asia-Pacific NIPT Market (by Country), 2017-2028, ($Million)
19    Asia-Pacific NIPT Market (by Country), 2017-2028, (Units)
20    Rest-of-the-World NIPT Market (by Test), 2017-2028, ($Million)
21    Rest-of-the-World NIPT Market (by Test), 2017-2028, (Units)

List of Figures

1    Impact of Market Drivers and Market Restraints
2    Market Statistics
3    Global NIPT Market (by Test), $Million
4    Global NIPT Market (by Test), Units
5    Global NIPT Market (by Method), 2017
6    Global NIPT Market (by Method), 2028
7    Global NIPT Market (by Application), 2017
8    Global NIPT Market (by Application), 2028
9    Global NIPT Market Value (by Region), 2017 and 2028
10    Global NIPT Market Volume (by Region), 2017 and 2028
11    Global NIPT Market (by Region), 2017
12    Global NIPT Market (by Region), 2028
13    Prenatal Testing Timeline During Pregnancy
14    Different Indications for NIPT
15    NIPT Approach
16    Benefits and Risks Associated with NIPT
17    Ecosystem Players of Global Prenatal Testing Market
18    Global Prenatal Testing Market: Opportunity Matrix
19    Global NIPT Market Value (2017-2028)
20    Global NIPT Market Volume (2017-2028)
21    Competitive Landscape (January 2014-August 2018)
22    Share of Key Developments and Strategies (January 2014-August 2018)
23    Product Launch Share, by Companies
24    Joint Ventures, Partnerships, and Collaborations Share, by Companies
25    Market Share Analysis
26    Growth Share Matrix (by Test), 2017
27    Growth Share Matrix (by Region), 2017
28    Porter’s Five Forces Analysis
29    Industry Insights (January 2014-August 2018)
30    Patent Share (by Assignee)
31    Classification of Tests in CLIA Program 
32    NIPT Market, by Test
33    Global NIPT Market (by Verifi), by Revenue, 2017-2028
34    Global NIPT Market (by Verifi), by Volume, 2017-2028
35    Global NIPT Market (by MaterniT21 PLUS and MaterniT GENOME), by Revenue, 2017-2028
36    Global NIPT Market (by MaterniT21 PLUS and MaterniT GENOME), by Volume, 2017-2028
37    Global NIPT Market (by PrenaTest, GeneSafe, and PrenatalSAFE), by Revenue, 2017-2028
38    Global NIPT Market (by PrenaTest, GeneSafe, and PrenatalSAFE), by Volume, 2017-2028
39    Global NIPT Market (by Panorama), by Revenue, 2017-2028
40    Global NIPT Market (by Panorama), by Volume, 2017-2028
41    Global NIPT Market (by QNatal Advanced), by Revenue, 2017-2028
42    Global NIPT Market (by QNatal Advanced), by Volume, 2017-2028
43    Global NIPT Market (by Harmony), by Revenue, 2017-2028
44    Global NIPT Market (by Harmony), by Volume, 2017-2028
45    Global NIPT Market (by IONA), by Revenue, 2017-2028
46    Global NIPT Market (by IONA), by Volume, 2017-2028
47    Global NIPT Market (by NIFTY), by Revenue, 2017-2028
48    Global NIPT Market (by NIFTY), by Volume, 2017-2028
49    Global NIPT Market (by Bambni), by Revenue, 2017-2028
50    Global NIPT Market (by Bambni), by Volume, 2017-2028
51    Global NIPT Market (by Others), by Revenue, 2017-2028
52    Global NIPT Market (by Others), by Volume, 2017-2028
53    Global NIPT Market Share (by Method), 2017
54    Global NIPT Market (by Method), by Revenue, 2017-2028
55    Global NIPT Market (by Method), by Volume, 2017-2028
56    Global NIPT Market (by cf-DNA), by Revenue, 2017-2028
57    Global NIPT Market (by cf-DNA), by Volume, 2017-2028
58    Global NIPT Market (by FCMB), by Revenue, 2017-2028
59    Global NIPT Market (by FCMB), by Volume, 2017-2028
60    Global NIPT Market Share (by Platform), 2017
61    Global NIPT Market (by Platform), by Revenue, 2017-2028
62    Global NIPT Market (by Platform), by Volume, 2017-2028
63    Global NIPT Market (by NGS), by Revenue, 2017-2028
64    Global NIPT Market (by NGS), by Volume, 2017-2028
65    Global NIPT Market (by MPSS), by Revenue, 2017-2028
66    Global NIPT Market (by MPSS), by Volume, 2017-2028
67    Global NIPT Market (by Others), by Revenue, 2017-2028
68    Global NIPT Market (by Others), by Volume, 2017-2028
69    Global NIPT Market Share (by Application), 2017
70    Global NIPT Market (by Application), by Revenue, 2017-2028
71    Global NIPT Market (by Application), by Volume, 2017-2028
72    Global NIPT Market (by Trisomy Detection), by Revenue, 2017-2028
73    Global NIPT Market (by Trisomy Detection), by Volume, 2017-2028
74    Global NIPT Market (by Microdeletion Detection), by Revenue, 2017-2028
75    Global NIPT Market (by Microdeletion Detection), by Volume, 2017-2028
76    Global NIPT Market (by Others), by Revenue, 2017-2028
77    Global NIPT Market (by Others), by Volume, 2017-2028
78    Global NIPT Market (by Region), by Revenue, 2017-2028
79    Global NIPT Market (by Region), by Volume, 2017-2028
80    Global NIPT Market Share, by Region (2017)
81    Global NIPT Market Share, by Region (2028)
82    North America NIPT Market, by Revenue, 2017-2028
83    North America NIPT Market, by Volume, 2017-2028
84    North America NIPT Market (by Country), by Revenue, 2017-2028
85    North America NIPT Market (by Country), by Volume, 2017-2028
86    The U.S. NIPT Market, by Revenue, 2017-2028
87    The U.S. NIPT Market, by Volume, 2017-2028
88    Canada NIPT Market, by Revenue, 2017-2028
89    Canada NIPT Market, by Volume, 2017-2028
90    Europe NIPT Market, by Revenue, 2017-2028
91    Europe NIPT Market, by Volume, 2017-2028
92    The U.K. NIPT Market, by Revenue, 2017-2028
93    The U.K. NIPT Market, by Volume, 2017-2028
94    Germany NIPT Market, by Revenue, 2017-2028
95    Germany NIPT Market, by Volume, 2017-2028
96    France NIPT Market, by Revenue, 2017-2028
97    France NIPT Market, by Volume, 2017-2028
98    Italy NIPT Market, by Revenue, 2017-2028
99    Italy NIPT Market, by Volume, 2017-2028
100    Spain NIPT Market, by Revenue, 2017-2028
101    Spain NIPT Market, by Volume, 2017-2028
102    The Netherlands NIPT Market, by Revenue, 2017-2028
103    The Netherlands NIPT Market, by Volume, 2017-2028
104    Belgium NIPT Market, by Revenue, 2017-2028
105    Belgium NIPT Market, by Volume, 2017-2028
106    Switzerland NIPT Market, by Revenue, 2017-2028
107    Switzerland NIPT Market, by Volume, 2017-2028
108    Sweden NIPT Market, by Revenue, 2017-2028
109    Sweden NIPT Market, by Volume, 2017-2028
110    Denmark NIPT Market, by Revenue, 2017-2028
111    Denmark NIPT Market, by Volume, 2017-2028
112    Poland NIPT Market, by Revenue, 2017-2028
113    Poland NIPT Market, by Volume, 2017-2028
114    Russia NIPT Market, by Revenue, 2017-2028
115    Russia NIPT Market, by Volume, 2017-2028
116    Rest-of-Europe NIPT Market, by Revenue, 2017-2028
117    Rest-of-Europe NIPT Market, by Volume, 2017-2028
118    Asia-Pacific NIPT Market, by Revenue, 2017-2028
119    Asia-Pacific NIPT Market, by Volume, 2017-2028
120    China NIPT Market, by Revenue, 2017-2028
121    China NIPT Market, by Volume, 2017-2028
122    Japan NIPT Market, by Revenue, 2017-2028
123    Japan NIPT Market, by Volume, 2017-2028
124    Australia NIPT Market, by Revenue, 2017-2028
125    Australia NIPT Market, by Volume, 2017-2028
126    India NIPT Market, by Revenue, 2017-2028
127    India NIPT Market, by Volume, 2017-2028
128    Singapore NIPT Market, by Revenue, 2017-2028
129    Singapore NIPT Market, by Volume, 2017-2028
130    Hong Kong NIPT Market, by Revenue, 2017-2028
131    Hong Kong NIPT Market, by Volume, 2017-2028
132    Malaysia NIPT Market, by Revenue, 2017-2028
133    Malaysia NIPT Market, by Volume, 2017-2028
134    Indonesia NIPT Market, by Revenue, 2017-2028
135    Indonesia NIPT Market, by Volume, 2017-2028
136    Vietnam NIPT Market, by Revenue, 2017-2028
137    Vietnam NIPT Market, by Volume, 2017-2028
138    South Korea NIPT Market, by Revenue, 2017-2028
139    South Korea NIPT Market, by Volume, 2017-2028
140    Philippines NIPT Market, by Revenue, 2017-2028
141    Philippines NIPT Market, by Volume, 2017-2028
142    Thailand NIPT Market, by Revenue, 2017-2028
143    Thailand NIPT Market, by Volume, 2017-2028
144    Rest-of-Asia-Pacific NIPT Market, by Revenue, 2017-2028
145    Rest-of-Asia-Pacific NIPT Market, by Volume, 2017-2028
146    Rest-of-the-World NIPT Market, by Revenue, 2017-2028
147    Rest-of-the-World NIPT Market, by Volume, 2017-2028
148    Share of Key Company Profiles (by Company Type)
149    Agilent Technologies, Inc.: Overall Product Portfolio
150    Agilent Technologies, Inc.: Product Portfolio for Global NIPT Market
151    Agilent Technologies, Inc.: Overall Financials (2015-2017)
152    Agilent Technologies, Inc.: Revenue by Business Segments (2015-2017)
153    Agilent Technologies, Inc.: Revenue by Region (2015-2017)
154    Agilent Technologies, Inc.: SWOT Analysis
155    Annoroad Gene Technology: Overall Product Portfolio
156    Annoroad Gene Technology: Product Portfolio for Global NIPT Market
157    Annoroad Gene Technology: SWOT Analysis
158    Berry Genomics Co., Ltd.: Overall Product Portfolio
159    Berry Genomics Co., Ltd.: Product Portfolio for Global NIPT Market
160    Berry Genomics Co., Ltd.: SWOT Analysis
161    BGI Diagnosis: Overall Product Portfolio
162    BGI Diagnosis: Product Portfolio for Global NIPT Market
163    BGI Diagnosis: SWOT Analysis
164    Centogene AG: Overall Product Portfolio
165    Centogene AG: Product Portfolio for Global NIPT Market
166    Centogene AG: SWOT Analysis
167    Myriad Genetics, Inc.: Overall Product Portfolio
168    Myriad Genetics, Inc.: Product Offerings for Global NIPT Market
169    Myriad Genetics, Inc.: Overall Financials (2015-2017)
170    Myriad Genetics, Inc.: Net Revenue by Business Segment (2015-2017)
171    Myriad Genetics, Inc.: SWOT Analysis
172    Eurofins Scientific: Overall Product Portfolio
173    Eurofins Scientific: Product Offerings for Global NIPT Market
174    Eurofins Scientific: Overall Financials (2015-2017)
175    Eurofins Scientific: Net Revenue by Region (2015-2017)
176    Eurofins Scientific: SWOT Analysis
177    F. Hoffmann-La Roche AG: Overall Product Portfolio
178    F. Hoffmann-La Roche AG: Product Portfolio for Global NIPT Market
179    F. Hoffmann-La Roche AG: Overall Financials (2015-2017)
180    F. Hoffmann-La Roche AG: Net Revenue by Business Segment (2015-2017)
181    F. Hoffmann-La Roche AG: Net Revenue by Diagnostics Sub-division (2015-2017)
182    F. Hoffmann-La Roche AG: Net Revenue by Region (2015-2017)
183    F. Hoffmann-La Roche AG: SWOT Analysis
184    Illumina, Inc.: Overall Product Portfolio
185    Illumina, Inc.: Product Offerings for Global NIPT Market
186    Illumina, Inc.: Overall Financials (2015-2017)
187    Illumina, Inc.: Net Revenue by Business Segment (2015-2017)
188    Illumina, Inc.: Net Revenue by Region (2015-2017)
189    Illumina, Inc.: SWOT Analysis
190    Natera, Inc.: Overall Product Portfolio
191    Natera, Inc.: Product Offerings for Global NIPT Market
192    Natera, Inc.: Overall Financials (2015-2017)
193    Natera, Inc.: Revenue by Region (2015-2017) 
194    Natera, Inc.: SWOT Analysis
195    Next Biosciences: Overall Product Portfolio
196    Next Biosciences: Product Portfolio for Global NIPT Market
197    Next Biosciences: SWOT Analysis
198    NIPD Genetics: Overall Product Portfolio
199    NIPD Genetics: Product Portfolio for Global NIPT Market
200    NIPD Genetics : SWOT Analysis
201    PerkinElmer, Inc.: Overall Product Portfolio
202    PerkinElmer, Inc.: Product Portfolio for Global NIPT Market
203    PerkinElmer, Inc.: Overall Financials (2015-2017) 
204    PerkinElmer, Inc.: Net Revenue by Business Segment (2015-2017)
205    PerkinElmer, Inc.: Net Revenue by Region (2015-2017)
206    PerkinElmer, Inc.: SWOT Analysis
207    Premaitha Health Plc: Overall Product Portfolio
208    Premaitha Health Plc: Product Portfolio for Global NIPT Market
209    Premaitha Health: Overall Financials (2015-2017)
210    Premaitha Health: Net Revenue by Region (2015-2017)
211    Premaitha Health Plc: SWOT Analysis
212    Quest Diagnostics Incorporated: Overall Product Portfolio
213    Quest Diagnostics Incorporated: Product Portfolio for Global NIPT Market
214    Quest Diagnostics Incorporated: Overall Financials (2015-2017)
215    Quest Diagnostics Incorporated: Net Revenue by Business Segment (2015-2017)
216    Quest Diagnostics Incorporated: Net Revenue by DIS Segment (2015-2017)
217    Quest Diagnostics Incorporated: SWOT Analysis
218    Laboratory Corporation of America Holdings : Overall Product Portfolio
219    Laboratory Corporation of America Holdings: Product Offerings for Global NIPT Market
220    Laboratory Corporation of America Holdings: Overall Financials  (2015-2017) 
221    Laboratory Corporation of America Holdings: Net Revenue by Business Segment (2015-2017)
222    Laboratory Corporation of America Holdings: Net Revenue by Region (2015-2017)
223    Laboratory Corporation of America Holdings: SWOT Analysis
224    Global NIPT Market Segmentation
225    Considered Factors for Data Prediction and Modeling

Non-invasive prenatal testing (NIPT) is a sophisticated method used for the screening of chromosomal abnormalities developing in the fetus. It is a novel genetic screening method based on the analysis of cell-free fetal deoxyribose nucleic acid (cff-DNA) in the maternal plasma. The genetic screening is performed between 10-22 weeks of time frame, with small amount of blood sample and requires a minimum of 10 weeks of pregnancy for apt results. It is commercializing at a rapid pace due to emerging technologies for non-invasive analysis of the fetal genome, thus reducing the cost-effectiveness of NIPT. The exponential growth of the NIPT market is supported by various factors, such as reimbursement policies, insurance coverage, high incidence rate of Down syndrome, no risk of miscarriage with NIPT, and shifting trend toward child birth at an advanced maternal age (35 years or above).

Since the past few years (2011-2017), prenatal genetic testing has come up with new innovative and non-invasive technologies and testing options. However, it has been a challenge for women’s healthcare providers to keep up with the swarm of publications and provide patients with the most accurate information regarding prenatal testing. Since a decade, researchers, physicians, and even pregnant women have been observing the benefits of a non-invasive tests that could potentially replace amniocentesis and chorionic villus sampling (CVS), and minimize the false positive results generated by them. Hence, with the advent of NIPT, there has been a reduction in the number of women undergoing highly invasive procedures.

The purpose of the study is to gain a holistic view of the NIPT market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the tests associated with the global NIPT market across different regions. The global NIPT market is segmented into five different parts namely by tets, by method, by platform, by application, and by region. The global market value and volume was estimated using these three different approaches and was validated with one another. The global NIPT market is expected to reach $5.67 billion with 7,591,792 units by 2028.

With the increasing demand for technological advancements in NIPT across various segments of the NIPT, the NIPT market is expected to witness rapid growth in the future. Further, the increasing insurance coverage and reimburesement policies in the developed markets such as the U.S., Japan, Germany, and the U.K. is the key driver for the growth of the NIPT market. Moreover, the Panorama test dominated the global NIPT market in 2017 among different commercialized tests. However, the IONA test is anticipated to witness the highest CAGR during the forecast period. The trisomy detection application of NIPT witnessed the highest industry demand. Further, the NGS platform for NIPT is also expected to witness impressive CAGR during the forecast period.

On the basis of regions, the global NIPT market is segmented into North America, Europe, Asia-Pacific, and Rest-of-the-World (RoW). North America is the leading contributor to the global NIPT market and contributed 51.55% and 52.31% in terms of revenue and volume respectively to the global market in 2017. However, Asia-Pacific is expected to grow at a CAGR of 18.01% and 19.13% in terms of revenue and volume respectively during the forecast period.

The key players who have been contributing significantly to the NIPT market include Agilent Technologies, Inc., Annoroad Gene Technology, Berry Genomics Co., Ltd., BGI Diagnosis, Centogene AG, Counsyl, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Next Biosciences, NIPD Genetics, PerkinElmer, Inc., Premaitha Health Plc, and Quest Diagnostics Incorporated, among others.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields
 

The life science industry is focused on the development of advanced NIPT tests using genome sequencing technologies for the early detection of genetic disorders. The increasing prevalence of genetic disorders and development of the healthcare infrastructure are promoting the adoption of the NIPT for better diagnosis and improved prenatal care.

Non-invasive prenatal testing (NIPT) is a sophisticated method used for the screening of chromosomal abnormalities developing in the fetus. Currently, NIPT is considered as a valuable test for the pregnant women to provide cost-effective and highly efficient early diagnosis of genetic disorders. Moreover, advancements in genome sequencing technologies reduce turnaround time and the complexity of diagnosis with next generation sequencing (NGS). The NGS technology provides several opportunities to develop the non-invasive diagnostic procedures for an early and accurate detection of various genetic disorders. The life science industry is witnessing significant growth of NIPT tests developed using the NGS technology. Several biotechnology companies are now indulging in the research and development of such NGS-based NIPT products. Furthermore, the advent of genome sequencing technologies in the life science industry has enabled the companies to detect the genetic diseases at an early stage and provide accurate results to remain competitive in the market.

The purpose of this study is to gain a holistic view of the NIPT market in terms of various influencing factors, such as recent trends, regulatory requirements, and technological advancements of the market. The scope of this report constitutes a detailed study of the tests associated with the global NIPT market across different regions. The market has been segmented into ‘tests,’ ‘methods,’ ‘platforms,’ ‘applications,’ and ‘regions.’ The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well-informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into consideration before entering the market.

This research report aims at answering various aspects of the global NIPT market with the help of the key factors driving the market, restraints, and challenges that can inhibit the overall market growth and the current growth opportunities that are going to shape the future trajectory of the market expansion. The report includes an in-depth examination of the key players and recent developments taking place in this market. Moreover, the report includes chapters on market dynamics (market drivers, opportunities, and challenges) and industry analysis as well.

The research study highlights the factors governing the industry attractiveness with Porter’s Five Forces for a comprehensive understanding of the global NIPT market. Moreover, the study includes detailed product mapping with further sub-segmentation in various countries, and in each sub-segment, the key market trends, list of the key companies, and the key strategies and developments have also been discussed.

The answers to the following key questions can be derived from this report:

•    How did the NIPT market evolve, and what is its scope in the future?
•    What are the major market drivers, challenges, and opportunities in the global NIPT market?
•    What are the key developmental strategies that are implemented by the key players to sustain in this market?
•    How the influencing factors will affect the industry attractiveness?
•    How NIPT is utilized for the detection of chromosomal abnormalities?
•    How investments by public and private companies and government organizations will affect the global NIPT market? 
•    What was the market size of the leading segments and sub-segments of the global NIPT market in 2017?
•    How will the industry evolve during the forecast period 2018-2028?
•    What will be the growth rate of the NIPT during the forecast period?
•    How will each segment of the global NIPT market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2028?
•    Which test segment, and application segment is expected to register the highest CAGR for the NIPT market?
•    What is the market size of NIPT in different countries of the world?
•    Which geographical region will contribute to the highest sales of NIPT?
•    Who are the key players in the NIPT market, and what are their contributions?

The key players who have been contributing significantly to the NIPT market include Agilent Technologies, Inc., Annoroad Gene Technology, Berry Genomics Co., Ltd., BGI Diagnosis, Centogene AG, Counsyl, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Next Biosciences, NIPD Genetics, PerkinElmer, Inc., Premaitha Health Plc, and Quest Diagnostics Incorporated, among others.

   Executive Summary
   1   Market Overview
        1.1   Introduction
        1.2   NIPT Approach
        1.3   Different Methods of NIPT
        1.4   Benefits and Risks Associated with NIPT
        1.5   Technological Advancements
        1.6   World Economic Outlook of Prenatal Testing Market, 2017
        1.7   Global NIPT Market Scenario
        1.8   Assumptions and Limitations for Market Size Calculations
 
   2   Market Dynamics
        2.1   Overview
        2.2   Impact Analysis
        2.3   Market Drivers
        2.4   Market Restraints
        2.5   Market Opportunities
 
   3   Competitive Landscape
        3.1   Introduction
        3.2   Key Developments and Strategies
                3.2.1   Product Launches and Enhancements
                3.2.2   Joint Ventures, Partnerships, and Collaborations
                3.2.3   Mergers and Acquisitions
                3.2.4   Business Expansions, Awards, Recognitions, Certifications, and Others
        3.3   Market Share Analysis
        3.4   Growth Share Matrix (by Test), 2017
        3.5   Growth Share Matrix (by Region), 2017
        3.6   Key Stakeholders of NIPT Market
        3.7   Industry Attractiveness
                3.7.1   Bargaining Power of Suppliers
                3.7.2   Bargaining Power of Buyers
                3.7.3   Threat of New Entrants
                3.7.4   Threat of Substitute Products
                3.7.5   Intensity of Competitive Rivalry
 
   4   Industry Insights
        4.1   Introduction
        4.2   Patent Analysis
        4.3   Clinical Laboratory Improvement Amendments (CLIA) Program
        4.4   List of Regulatory Bodies
 
   5   Global Non-Invasive Prenatal Testing (NIPT) Market (by Test)
        5.1   Overview
        5.2   Verifi
        5.3   MaterniT21 PLUS and MaterniT GENOME
        5.4   PrenaTest, GeneSafe, and PrenatalSAFE
        5.5   Panorama
        5.6   QNatal Advanced
        5.7   Harmony
        5.8   IONA
        5.9   NIFTY
       5.10  Bambni
       5.11  Others
 
   6   Global Non-Invasive Prenatal Testing (NIPT) Market (by Method)
        6.1   Overview
        6.2   cf-DNA
        6.3   FCMB
 
   7   Global Non-Invasive Prenatal Testing (NIPT) Market (by Platform)
        7.1   Overview
        7.2   NGS
        7.3   MPSS
        7.4   Others
 
   8   Global Non-Invasive Prenatal Testing (NIPT) Market (by Application)
        8.1   Overview
        8.2   Trisomy Detection
        8.3   Microdeletion Detection
        8.4   Others
 
   9   Global Non-Invasive Prenatal Testing (NIPT) Market (by Region)
        9.1   Overview
        9.2   Global Insights
        9.3   North America
                9.3.1   North America Market Dynamics
                9.3.2   North America Market (by Country)
                           9.3.2.1   The U.S.
                           9.3.2.2   Canada
        9.4   Europe
                9.4.1   Europe Market Dynamics
                9.4.2   Europe Market (by Country)
                           9.4.2.1   The U.K.
                           9.4.2.2   Germany
                           9.4.2.3   France
                           9.4.2.4   Italy
                           9.4.2.5   Spain
                           9.4.2.6   The Netherlands
                           9.4.2.7   Belgium
                           9.4.2.8   Switzerland
                           9.4.2.9   Sweden
                           9.4.2.10  Denmark
                           9.4.2.11  Poland
                           9.4.2.12  Russia
                           9.4.2.13  Rest-of-Europe
        9.5   Asia-Pacific
               9.5.1   Asia-Pacific Market Dynamics
               9.5.2   Asia-Pacific (by Country)
                          9.5.2.1   China
                          9.5.2.2   Japan
                          9.5.2.3   Australia
                          9.5.2.4   India
                          9.5.2.5   Singapore
                          9.5.2.6   Hong Kong 
                          9.5.2.7   Malaysia
                          9.5.2.8   Indonesia
                          9.5.2.9   Vietnam
                          9.5.2.10  South Korea
                          9.5.2.11  Philippines
                          9.5.2.12  Thailand
                          9.5.2.13  Rest-of-Asia-Pacific
        9.6   Rest-of-the-World
 
   10   Company Profiles
          10.1   Overview
          10.2   Agilent Technologies, Inc.
                    10.2.1   Overview
                    10.2.2   Corporate Summary
                    10.2.3   Product Offerings for Global NIPT Market
                    10.2.4   Financials
                                 10.2.4.1   Financial Summary
                    10.2.5   SWOT Analysis
          10.3   Annoroad Gene Technology
                    10.3.1   Overview
                    10.3.2   Corporate Summary
                    10.3.3   Product Offerings for Global NIPT Market
                    10.3.4   SWOT Analysis
          10.4   Berry Genomics Co., Ltd.
                    10.4.1   Overview
                    10.4.2   Corporate Summary
                    10.4.3   Product Offerings for Global NIPT Market
                    10.4.4   SWOT Analysis
          10.5   BGI Diagnosis
                    10.5.1   Overview
                    10.5.2   Corporate Summary
                    10.5.3   Product Offerings for Global NIPT Market
                    10.5.4   SWOT Analysis
          10.6   Centogene AG
                    10.6.1   Overview
                    10.6.2   Corporate Summary
                    10.6.3   Product Offerings for Global NIPT Market
                    10.6.4   SWOT Analysis
          10.7   Counsyl, Inc. (Subsidiary of  Myriad Genetics, Inc.)
                    10.7.1   Overview
          10.8   Myriad Genetics, Inc.
                    10.8.1   Overview
                    10.8.2   Corporate Summary
                    10.8.3   Product Offerings for Global NIPT Market
                    10.8.4   Financials
                                 10.8.4.1   Financial Summary
                    10.8.5   SWOT Analysis
          10.9   LifeCodexx AG (Subsidiary of Eurofins Scientific)
                    10.9.1   Overview
         10.10  EUROFINS Genoma Group (Subsidiary of Eurofins Scientific)
                    10.10.1   Overview
         10.11  Eurofins Scientific
                   10.11.1   Overview
                   10.11.2   Corporate Summary
                   10.11.3   Product Offerings for Global NIPT Market
                   10.11.4   Financials
                                  10.11.4.1   Financial Summary
                   10.11.5   SWOT Analysis
         10.12  F. Hoffmann-La Roche AG
                    10.12.1   Overview
                    10.12.2   Corporate Summary
                    10.12.3   Product Offerings for Global NIPT Market
                    10.12.4   Financials
                                   10.12.4.1   Financial Summary
                    10.12.5   SWOT Analysis
          10.13  Illumina, Inc.
                     10.13.1   Overview
                     10.13.2   Corporate Summary
                     10.13.3   Product Offerings for Global NIPT Market
                     10.13.4   Financials
                                    10.13.4.1   Financial Summary
                      10.13.5   SWOT Analysis
           10.14  Natera, Inc.
                      10.14.1   Overview
                      10.14.2   Corporate Summary
                      10.14.3   Product Offerings for Global NIPT Market
                      10.14.4   Financials
                                     10.14.4.1   Financial Summary
                       10.14.5   SWOT Analysis
            10.15  Next Biosciences
                       10.15.1   Overview
                       10.15.2   Corporate Summary
                       10.15.3   Product Offerings for Global NIPT Market
                       10.15.4   SWOT Analysis
            10.16  NIPD Genetics
                       10.16.1   Overview
                       10.16.2   Corporate Summary
                       10.16.3   Product Offerings for Global NIPT Market
                       10.16.4   SWOT Analysis
            10.17  PerkinElmer, Inc.
                       10.17.1   Overview
                       10.17.2   Corporate Summary
                       10.17.3   Product Offerings for Global NIPT Market
                       10.17.4   Financials
                                      10.17.4.1   Financial Summary
                       10.17.5   SWOT Analysis
            10.18  Premaitha Health Plc
                       10.18.1   Overview
                       10.18.2   Corporate Summary
                       10.18.3   Product Offerings for Global NIPT Market
                       10.18.4   Financials
                                      10.18.4.1   Financial Summary
                       10.18.5   SWOT Analysis
            10.19  Quest Diagnostics Incorporated
                       10.19.1   Overview
                       10.19.2   Corporate Summary
                       10.19.3   Product Offerings for Global NIPT Market
                       10.19.4   Financials
                                      10.19.4.1   Financial Summary
                       10.19.5   SWOT Analysis
            10.20  Sequenom, Inc. (Subsidiary of Laboratory Corporation of America Holdings)
                       10.20.1   Overview
            10.21   Laboratory Corporation of America Holdings
                        10.21.1   Overview
                        10.21.2   Corporate Summary
                        10.21.3   Product Offerings for Global NIPT Market
                        10.21.4   Financials
                                       10.21.4.1   Financial Summary
                        10.21.5   SWOT Analysis
 
   11   Report Scope and Methodology
          11.1   Scope of the Report
          11.2   Global NIPT Market Segmentation
          11.3   Research Methodology
                    11.3.1   Primary Research
                    11.3.2   Secondary Research
                    11.3.3   Key Data Points from Primary Sources 
                    11.3.4   Key Data Points from Secondary Sources 
                    11.3.5   Data Triangulation
                    11.3.6   Top-Down Approach (Segment Wise Analysis)
                    11.3.7   Bottom-Up Approach (Segmental Analysis)
          11.4   Assumptions and Limitations
          11.5   Data and Prediction Modelling
 
I    Annexure 1: Recent Key Developments (2014 – 2018)
II   Annexure 2: Product Mapping
III  Annexure 3: Patent Landscape
 

List of Tables

1    Global NIPT Market (2017 and 2028)
2    Major Chromosomal Aneuploidies
3    Incidence Rate of Major Chromosomal Aneuploidies
4    Technological Approach for NIPT
5    Impact Analysis of Market Dynamics
6    List of Regulatory Authorities involved in CLIA Program 
7    List of Regulatory Bodies
8    NIPT Market (by Test), 2017-2028, ($Million)
9    NIPT Market (by Test), 2017-2028, (Units)
10    North America NIPT Market (by Test), 2017-2028, ($Million)
11    North America NIPT Market (by Test), 2017-2028, (Units)
12    Europe NIPT Market (by Test), 2017-2028, ($Million)
13    Europe NIPT Market (by Test), 2017-2028, (Units)
14    Europe NIPT Market (by Country), 2017-2028, ($Million)
15    Europe NIPT Market (by Country), 2017-2028, (Units)
16    Asia-Pacific NIPT Market (by Test), 2017-2028, ($Million)
17    Asia-Pacific NIPT Market (by Test), 2017-2028, (Units)
18    Asia-Pacific NIPT Market (by Country), 2017-2028, ($Million)
19    Asia-Pacific NIPT Market (by Country), 2017-2028, (Units)
20    Rest-of-the-World NIPT Market (by Test), 2017-2028, ($Million)
21    Rest-of-the-World NIPT Market (by Test), 2017-2028, (Units)

List of Figures

1    Impact of Market Drivers and Market Restraints
2    Market Statistics
3    Global NIPT Market (by Test), $Million
4    Global NIPT Market (by Test), Units
5    Global NIPT Market (by Method), 2017
6    Global NIPT Market (by Method), 2028
7    Global NIPT Market (by Application), 2017
8    Global NIPT Market (by Application), 2028
9    Global NIPT Market Value (by Region), 2017 and 2028
10    Global NIPT Market Volume (by Region), 2017 and 2028
11    Global NIPT Market (by Region), 2017
12    Global NIPT Market (by Region), 2028
13    Prenatal Testing Timeline During Pregnancy
14    Different Indications for NIPT
15    NIPT Approach
16    Benefits and Risks Associated with NIPT
17    Ecosystem Players of Global Prenatal Testing Market
18    Global Prenatal Testing Market: Opportunity Matrix
19    Global NIPT Market Value (2017-2028)
20    Global NIPT Market Volume (2017-2028)
21    Competitive Landscape (January 2014-August 2018)
22    Share of Key Developments and Strategies (January 2014-August 2018)
23    Product Launch Share, by Companies
24    Joint Ventures, Partnerships, and Collaborations Share, by Companies
25    Market Share Analysis
26    Growth Share Matrix (by Test), 2017
27    Growth Share Matrix (by Region), 2017
28    Porter’s Five Forces Analysis
29    Industry Insights (January 2014-August 2018)
30    Patent Share (by Assignee)
31    Classification of Tests in CLIA Program 
32    NIPT Market, by Test
33    Global NIPT Market (by Verifi), by Revenue, 2017-2028
34    Global NIPT Market (by Verifi), by Volume, 2017-2028
35    Global NIPT Market (by MaterniT21 PLUS and MaterniT GENOME), by Revenue, 2017-2028
36    Global NIPT Market (by MaterniT21 PLUS and MaterniT GENOME), by Volume, 2017-2028
37    Global NIPT Market (by PrenaTest, GeneSafe, and PrenatalSAFE), by Revenue, 2017-2028
38    Global NIPT Market (by PrenaTest, GeneSafe, and PrenatalSAFE), by Volume, 2017-2028
39    Global NIPT Market (by Panorama), by Revenue, 2017-2028
40    Global NIPT Market (by Panorama), by Volume, 2017-2028
41    Global NIPT Market (by QNatal Advanced), by Revenue, 2017-2028
42    Global NIPT Market (by QNatal Advanced), by Volume, 2017-2028
43    Global NIPT Market (by Harmony), by Revenue, 2017-2028
44    Global NIPT Market (by Harmony), by Volume, 2017-2028
45    Global NIPT Market (by IONA), by Revenue, 2017-2028
46    Global NIPT Market (by IONA), by Volume, 2017-2028
47    Global NIPT Market (by NIFTY), by Revenue, 2017-2028
48    Global NIPT Market (by NIFTY), by Volume, 2017-2028
49    Global NIPT Market (by Bambni), by Revenue, 2017-2028
50    Global NIPT Market (by Bambni), by Volume, 2017-2028
51    Global NIPT Market (by Others), by Revenue, 2017-2028
52    Global NIPT Market (by Others), by Volume, 2017-2028
53    Global NIPT Market Share (by Method), 2017
54    Global NIPT Market (by Method), by Revenue, 2017-2028
55    Global NIPT Market (by Method), by Volume, 2017-2028
56    Global NIPT Market (by cf-DNA), by Revenue, 2017-2028
57    Global NIPT Market (by cf-DNA), by Volume, 2017-2028
58    Global NIPT Market (by FCMB), by Revenue, 2017-2028
59    Global NIPT Market (by FCMB), by Volume, 2017-2028
60    Global NIPT Market Share (by Platform), 2017
61    Global NIPT Market (by Platform), by Revenue, 2017-2028
62    Global NIPT Market (by Platform), by Volume, 2017-2028
63    Global NIPT Market (by NGS), by Revenue, 2017-2028
64    Global NIPT Market (by NGS), by Volume, 2017-2028
65    Global NIPT Market (by MPSS), by Revenue, 2017-2028
66    Global NIPT Market (by MPSS), by Volume, 2017-2028
67    Global NIPT Market (by Others), by Revenue, 2017-2028
68    Global NIPT Market (by Others), by Volume, 2017-2028
69    Global NIPT Market Share (by Application), 2017
70    Global NIPT Market (by Application), by Revenue, 2017-2028
71    Global NIPT Market (by Application), by Volume, 2017-2028
72    Global NIPT Market (by Trisomy Detection), by Revenue, 2017-2028
73    Global NIPT Market (by Trisomy Detection), by Volume, 2017-2028
74    Global NIPT Market (by Microdeletion Detection), by Revenue, 2017-2028
75    Global NIPT Market (by Microdeletion Detection), by Volume, 2017-2028
76    Global NIPT Market (by Others), by Revenue, 2017-2028
77    Global NIPT Market (by Others), by Volume, 2017-2028
78    Global NIPT Market (by Region), by Revenue, 2017-2028
79    Global NIPT Market (by Region), by Volume, 2017-2028
80    Global NIPT Market Share, by Region (2017)
81    Global NIPT Market Share, by Region (2028)
82    North America NIPT Market, by Revenue, 2017-2028
83    North America NIPT Market, by Volume, 2017-2028
84    North America NIPT Market (by Country), by Revenue, 2017-2028
85    North America NIPT Market (by Country), by Volume, 2017-2028
86    The U.S. NIPT Market, by Revenue, 2017-2028
87    The U.S. NIPT Market, by Volume, 2017-2028
88    Canada NIPT Market, by Revenue, 2017-2028
89    Canada NIPT Market, by Volume, 2017-2028
90    Europe NIPT Market, by Revenue, 2017-2028
91    Europe NIPT Market, by Volume, 2017-2028
92    The U.K. NIPT Market, by Revenue, 2017-2028
93    The U.K. NIPT Market, by Volume, 2017-2028
94    Germany NIPT Market, by Revenue, 2017-2028
95    Germany NIPT Market, by Volume, 2017-2028
96    France NIPT Market, by Revenue, 2017-2028
97    France NIPT Market, by Volume, 2017-2028
98    Italy NIPT Market, by Revenue, 2017-2028
99    Italy NIPT Market, by Volume, 2017-2028
100    Spain NIPT Market, by Revenue, 2017-2028
101    Spain NIPT Market, by Volume, 2017-2028
102    The Netherlands NIPT Market, by Revenue, 2017-2028
103    The Netherlands NIPT Market, by Volume, 2017-2028
104    Belgium NIPT Market, by Revenue, 2017-2028
105    Belgium NIPT Market, by Volume, 2017-2028
106    Switzerland NIPT Market, by Revenue, 2017-2028
107    Switzerland NIPT Market, by Volume, 2017-2028
108    Sweden NIPT Market, by Revenue, 2017-2028
109    Sweden NIPT Market, by Volume, 2017-2028
110    Denmark NIPT Market, by Revenue, 2017-2028
111    Denmark NIPT Market, by Volume, 2017-2028
112    Poland NIPT Market, by Revenue, 2017-2028
113    Poland NIPT Market, by Volume, 2017-2028
114    Russia NIPT Market, by Revenue, 2017-2028
115    Russia NIPT Market, by Volume, 2017-2028
116    Rest-of-Europe NIPT Market, by Revenue, 2017-2028
117    Rest-of-Europe NIPT Market, by Volume, 2017-2028
118    Asia-Pacific NIPT Market, by Revenue, 2017-2028
119    Asia-Pacific NIPT Market, by Volume, 2017-2028
120    China NIPT Market, by Revenue, 2017-2028
121    China NIPT Market, by Volume, 2017-2028
122    Japan NIPT Market, by Revenue, 2017-2028
123    Japan NIPT Market, by Volume, 2017-2028
124    Australia NIPT Market, by Revenue, 2017-2028
125    Australia NIPT Market, by Volume, 2017-2028
126    India NIPT Market, by Revenue, 2017-2028
127    India NIPT Market, by Volume, 2017-2028
128    Singapore NIPT Market, by Revenue, 2017-2028
129    Singapore NIPT Market, by Volume, 2017-2028
130    Hong Kong NIPT Market, by Revenue, 2017-2028
131    Hong Kong NIPT Market, by Volume, 2017-2028
132    Malaysia NIPT Market, by Revenue, 2017-2028
133    Malaysia NIPT Market, by Volume, 2017-2028
134    Indonesia NIPT Market, by Revenue, 2017-2028
135    Indonesia NIPT Market, by Volume, 2017-2028
136    Vietnam NIPT Market, by Revenue, 2017-2028
137    Vietnam NIPT Market, by Volume, 2017-2028
138    South Korea NIPT Market, by Revenue, 2017-2028
139    South Korea NIPT Market, by Volume, 2017-2028
140    Philippines NIPT Market, by Revenue, 2017-2028
141    Philippines NIPT Market, by Volume, 2017-2028
142    Thailand NIPT Market, by Revenue, 2017-2028
143    Thailand NIPT Market, by Volume, 2017-2028
144    Rest-of-Asia-Pacific NIPT Market, by Revenue, 2017-2028
145    Rest-of-Asia-Pacific NIPT Market, by Volume, 2017-2028
146    Rest-of-the-World NIPT Market, by Revenue, 2017-2028
147    Rest-of-the-World NIPT Market, by Volume, 2017-2028
148    Share of Key Company Profiles (by Company Type)
149    Agilent Technologies, Inc.: Overall Product Portfolio
150    Agilent Technologies, Inc.: Product Portfolio for Global NIPT Market
151    Agilent Technologies, Inc.: Overall Financials (2015-2017)
152    Agilent Technologies, Inc.: Revenue by Business Segments (2015-2017)
153    Agilent Technologies, Inc.: Revenue by Region (2015-2017)
154    Agilent Technologies, Inc.: SWOT Analysis
155    Annoroad Gene Technology: Overall Product Portfolio
156    Annoroad Gene Technology: Product Portfolio for Global NIPT Market
157    Annoroad Gene Technology: SWOT Analysis
158    Berry Genomics Co., Ltd.: Overall Product Portfolio
159    Berry Genomics Co., Ltd.: Product Portfolio for Global NIPT Market
160    Berry Genomics Co., Ltd.: SWOT Analysis
161    BGI Diagnosis: Overall Product Portfolio
162    BGI Diagnosis: Product Portfolio for Global NIPT Market
163    BGI Diagnosis: SWOT Analysis
164    Centogene AG: Overall Product Portfolio
165    Centogene AG: Product Portfolio for Global NIPT Market
166    Centogene AG: SWOT Analysis
167    Myriad Genetics, Inc.: Overall Product Portfolio
168    Myriad Genetics, Inc.: Product Offerings for Global NIPT Market
169    Myriad Genetics, Inc.: Overall Financials (2015-2017)
170    Myriad Genetics, Inc.: Net Revenue by Business Segment (2015-2017)
171    Myriad Genetics, Inc.: SWOT Analysis
172    Eurofins Scientific: Overall Product Portfolio
173    Eurofins Scientific: Product Offerings for Global NIPT Market
174    Eurofins Scientific: Overall Financials (2015-2017)
175    Eurofins Scientific: Net Revenue by Region (2015-2017)
176    Eurofins Scientific: SWOT Analysis
177    F. Hoffmann-La Roche AG: Overall Product Portfolio
178    F. Hoffmann-La Roche AG: Product Portfolio for Global NIPT Market
179    F. Hoffmann-La Roche AG: Overall Financials (2015-2017)
180    F. Hoffmann-La Roche AG: Net Revenue by Business Segment (2015-2017)
181    F. Hoffmann-La Roche AG: Net Revenue by Diagnostics Sub-division (2015-2017)
182    F. Hoffmann-La Roche AG: Net Revenue by Region (2015-2017)
183    F. Hoffmann-La Roche AG: SWOT Analysis
184    Illumina, Inc.: Overall Product Portfolio
185    Illumina, Inc.: Product Offerings for Global NIPT Market
186    Illumina, Inc.: Overall Financials (2015-2017)
187    Illumina, Inc.: Net Revenue by Business Segment (2015-2017)
188    Illumina, Inc.: Net Revenue by Region (2015-2017)
189    Illumina, Inc.: SWOT Analysis
190    Natera, Inc.: Overall Product Portfolio
191    Natera, Inc.: Product Offerings for Global NIPT Market
192    Natera, Inc.: Overall Financials (2015-2017)
193    Natera, Inc.: Revenue by Region (2015-2017) 
194    Natera, Inc.: SWOT Analysis
195    Next Biosciences: Overall Product Portfolio
196    Next Biosciences: Product Portfolio for Global NIPT Market
197    Next Biosciences: SWOT Analysis
198    NIPD Genetics: Overall Product Portfolio
199    NIPD Genetics: Product Portfolio for Global NIPT Market
200    NIPD Genetics : SWOT Analysis
201    PerkinElmer, Inc.: Overall Product Portfolio
202    PerkinElmer, Inc.: Product Portfolio for Global NIPT Market
203    PerkinElmer, Inc.: Overall Financials (2015-2017) 
204    PerkinElmer, Inc.: Net Revenue by Business Segment (2015-2017)
205    PerkinElmer, Inc.: Net Revenue by Region (2015-2017)
206    PerkinElmer, Inc.: SWOT Analysis
207    Premaitha Health Plc: Overall Product Portfolio
208    Premaitha Health Plc: Product Portfolio for Global NIPT Market
209    Premaitha Health: Overall Financials (2015-2017)
210    Premaitha Health: Net Revenue by Region (2015-2017)
211    Premaitha Health Plc: SWOT Analysis
212    Quest Diagnostics Incorporated: Overall Product Portfolio
213    Quest Diagnostics Incorporated: Product Portfolio for Global NIPT Market
214    Quest Diagnostics Incorporated: Overall Financials (2015-2017)
215    Quest Diagnostics Incorporated: Net Revenue by Business Segment (2015-2017)
216    Quest Diagnostics Incorporated: Net Revenue by DIS Segment (2015-2017)
217    Quest Diagnostics Incorporated: SWOT Analysis
218    Laboratory Corporation of America Holdings : Overall Product Portfolio
219    Laboratory Corporation of America Holdings: Product Offerings for Global NIPT Market
220    Laboratory Corporation of America Holdings: Overall Financials  (2015-2017) 
221    Laboratory Corporation of America Holdings: Net Revenue by Business Segment (2015-2017)
222    Laboratory Corporation of America Holdings: Net Revenue by Region (2015-2017)
223    Laboratory Corporation of America Holdings: SWOT Analysis
224    Global NIPT Market Segmentation
225    Considered Factors for Data Prediction and Modeling

Non-invasive prenatal testing (NIPT) is a sophisticated method used for the screening of chromosomal abnormalities developing in the fetus. It is a novel genetic screening method based on the analysis of cell-free fetal deoxyribose nucleic acid (cff-DNA) in the maternal plasma. The genetic screening is performed between 10-22 weeks of time frame, with small amount of blood sample and requires a minimum of 10 weeks of pregnancy for apt results. It is commercializing at a rapid pace due to emerging technologies for non-invasive analysis of the fetal genome, thus reducing the cost-effectiveness of NIPT. The exponential growth of the NIPT market is supported by various factors, such as reimbursement policies, insurance coverage, high incidence rate of Down syndrome, no risk of miscarriage with NIPT, and shifting trend toward child birth at an advanced maternal age (35 years or above).

Since the past few years (2011-2017), prenatal genetic testing has come up with new innovative and non-invasive technologies and testing options. However, it has been a challenge for women’s healthcare providers to keep up with the swarm of publications and provide patients with the most accurate information regarding prenatal testing. Since a decade, researchers, physicians, and even pregnant women have been observing the benefits of a non-invasive tests that could potentially replace amniocentesis and chorionic villus sampling (CVS), and minimize the false positive results generated by them. Hence, with the advent of NIPT, there has been a reduction in the number of women undergoing highly invasive procedures.

The purpose of the study is to gain a holistic view of the NIPT market in terms of various factors influencing it such as recent trends and technological advancements of the market. The scope of this report is centered upon conducting a detailed study of the tests associated with the global NIPT market across different regions. The global NIPT market is segmented into five different parts namely by tets, by method, by platform, by application, and by region. The global market value and volume was estimated using these three different approaches and was validated with one another. The global NIPT market is expected to reach $5.67 billion with 7,591,792 units by 2028.

With the increasing demand for technological advancements in NIPT across various segments of the NIPT, the NIPT market is expected to witness rapid growth in the future. Further, the increasing insurance coverage and reimburesement policies in the developed markets such as the U.S., Japan, Germany, and the U.K. is the key driver for the growth of the NIPT market. Moreover, the Panorama test dominated the global NIPT market in 2017 among different commercialized tests. However, the IONA test is anticipated to witness the highest CAGR during the forecast period. The trisomy detection application of NIPT witnessed the highest industry demand. Further, the NGS platform for NIPT is also expected to witness impressive CAGR during the forecast period.

On the basis of regions, the global NIPT market is segmented into North America, Europe, Asia-Pacific, and Rest-of-the-World (RoW). North America is the leading contributor to the global NIPT market and contributed 51.55% and 52.31% in terms of revenue and volume respectively to the global market in 2017. However, Asia-Pacific is expected to grow at a CAGR of 18.01% and 19.13% in terms of revenue and volume respectively during the forecast period.

The key players who have been contributing significantly to the NIPT market include Agilent Technologies, Inc., Annoroad Gene Technology, Berry Genomics Co., Ltd., BGI Diagnosis, Centogene AG, Counsyl, Inc., Eurofins Scientific, F. Hoffmann-La Roche AG, Illumina, Inc., Laboratory Corporation of America Holdings, Natera, Inc., Next Biosciences, NIPD Genetics, PerkinElmer, Inc., Premaitha Health Plc, and Quest Diagnostics Incorporated, among others.

We understand that your business need specific answers pertaining to the market. And , therefore, we do provide customised research tailored to your need.

With the purchase of this report, you are entitled to certain degree of free customisation within the scope of the study.

Do get in touch to help us understand how we can serve u better with a custom solution to your research needs. We assure quick turnaround for your pressing business requirements.

Contact Information


Name *
Email *
 
Company Name *
Designation
 
 
Contact No. *
Other Details
 
 

Write the characters in the image above
 
 
* Required Fields


related reports





Get yourself updated on key emerging technology markets

Know about our market intelligence coverage in key sectors